Skip to main content
. 2023 Apr 28;13:6993. doi: 10.1038/s41598-023-34166-z

Table 2.

Prognostic factors associated with mortality of COVID-19 cohort.

Item HR (95%CI) p value
Age
 18–49 1.0
 50–62 1.6 (1.4, 1.9)  < 0.001
 63–75 2.3 (2.0, 2.7)  < 0.001
 76–104 4.3 (3.8, 4.9)  < 0.001
Male gender 1.1 (1.0, 1.2) 0.012
WBC < 3500 1.2 (1.0, 1.4) 0.033
WBC > 9500 1.8 (1.7, 2.0)  < 0.001
Neutrophils count > 6300 0.6 (0.5, 0.6)  < 0.001
Lymphocyte count < 1200 1.1 (1.0, 1.2) 0.009
MCV < 80 0.8 (0.8, 0.9) 0.001
CRP > 10 1.4 (1.2, 1.6)  < 0.001
PCO2 > 50 1.0 (0.9, 1.1) 0.775
Cr > 1.2 2.1 (2.0, 2.3)  < 0.001
BUN > 23 2.9 (2.6, 3.3)  < 0.001
Potassium > 5.1 2.1 (1.9, 2.4)  < 0.001
PT > 12.5 1.1 (1.0, 1.1)  < 0.001
Log ALP* 1.4 (1.3, 1.5)  < 0.001
Total bilirubin > 1.2 1.6 (1.4, 1.7)  < 0.001
Direct bilirubin > 0.3 1.7 (1.5, 1.9)  < 0.001
CPK > 200 1.4 (1.3, 1.6)  < 0.001
Log CK-MB* 1.4 (1.3, 1.4)  < 0.001
LDH > 250 1.2 (0.8, 1.9) 0.404
Troponin > 0.04 2.5 (2.3, 2.8)  < 0.001
D-DIMER > 250 1.4 (1.2, 1.7)  < 0.001

Footnote The Cox regression was used to analyze the impact of the variable on time to death of patients with COVID-19. MCV Mean corpuscular volume, CRP C-reactive protein, Cr Creatinine, BUN Blood urea nitrogen, PT Prothrombin time, ALP Alkaline phosphatase, CPK Creatine kinase, LDH Lactate dehydrogenase.

*The CK-MB and ALP are presented in logarithmic scale since the non-logarithmic hazard ratio is close to 1, and logarithmic transformation was used to facilitate interpretation.